Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes—proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS

Myelodysplastic syndromes: 2014 update on diagnosis, risk-stratification, and management

(2014) Guillermo Garcia-Manero   AMERICAN JOURNAL OF HEMATOLOGY

Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R

(2014) M. G. Della Porta et al.   BLOOD

Absence of aberrant myeloid progenitors by flow cytometry is associated with favorable response to azacitidine in higher risk myelodysplastic syndromes

(2014) Canan Alhan et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Erythropoiesis stimulating agents and other growth factors in low-risk MDS

(2013) Eva Hellström-Lindberg et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet

(2013) L. Malcovati et al.   BLOOD

Clinical and biological implications of driver mutations in myelodysplastic syndromes

(2013) E. Papaemmanuil et al.   BLOOD

Multiparameter flow cytometry reveals myelodysplasia-related aberrant antigen expression in myelodysplastic/myeloproliferative neoplasms

(2013) Wolfgang Kern et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Combined flow cytometric assessment of CD45, HLA-DR, CD34, and CD117 expression is a useful approach for reliable quantification of blast cells in myelodysplastic syndromes

(2013) Alex F. Sandes et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Diagnostic application and clinical significance of FCM progress scoring system based on immunophenotyping in CD34+ blasts in myelodysplastic syndromes

(2013) Feng Xu et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Validation of cell-based fluorescence assays: Practice guidelines from the ICSH and ICCS - part V - assay performance criteria

(2013) Brent Wood et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Single nucleotide polymorphism array karyotyping: A diagnostic and prognostic tool in myelodysplastic syndromes with unsuccessful conventional cytogenetic testing

(2013) Leonor Arenillas et al.   GENES CHROMOSOMES & CANCER

Applicability of a reproducible flow cytometry scoring system in the diagnosis of refractory cytopenia of childhood

(2013) A M Aalbers et al.   LEUKEMIA

Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromes

(2013) S Mathis et al.   LEUKEMIA

Landscape of genetic lesions in 944 patients with myelodysplastic syndromes

(2013) T Haferlach et al.   LEUKEMIA

Role of flow cytometry in myelodysplastic syndromes: diagnosis, classification, prognosis and response assessment

(2013) Kate L. Burbury et al.   LEUKEMIA & LYMPHOMA

CD56+ monocytes have a dysregulated cytokine response to lipopolysaccharide and accumulate in rheumatoid arthritis and immunosenescence

(2013) Marco Krasselt et al.   ARTHRITIS RESEARCH & THERAPY

The need for additional genetic markers for myelodysplastic syndrome stratification: what does the future hold for prognostication?

(2013) Zaher K Otrock et al.   Expert Review of Hematology

Diagnostic Potential of CD34+ Cell Antigen Expression in Myelodysplastic Syndromes

(2012) Dieter De Smet et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Flow cytometry in myelodysplastic syndrome: analysis of diagnostic utility using maturation pattern-based and quantitative approaches

(2012) Anita Chopra et al.   ANNALS OF HEMATOLOGY

Revised International Prognostic Scoring System for Myelodysplastic Syndromes

(2012) P. L. Greenberg et al.   BLOOD

Altered immunophenotypic features of peripheral blood platelets in myelodysplastic syndromes

(2012) A. F. Sandes et al.   HAEMATOLOGICA

Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study

(2012) M. G. Della Porta et al.   HAEMATOLOGICA

Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group

(2012) T M Westers et al.   LEUKEMIA

EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes

(2012) J J M van Dongen et al.   LEUKEMIA

Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an International Consortium and the European LeukemiaNet Working Group

(2012) Arjan A. van de Loosdrecht et al.   LEUKEMIA & LYMPHOMA

Differences in blast immunophenotypes among disease types in myelodysplastic syndromes: A multicenter validation study

(2012) Kiyoyuki Ogata et al.   LEUKEMIA RESEARCH

Flow cytometry immunophenotyping for the evaluation of bone marrow dysplasia

(2011) Matteo Giovanni Della Porta et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Prognostic relevance of cytometric quantitative assessment in patients with myelodysplastic syndromes

(2011) Patrizia Falco et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Immunophenotypic analysis of erythroid dysplasia and its diagnostic application in myelodysplastic syndromes

(2011) F. Xu et al.   INTERNAL MEDICINE JOURNAL

Coalesced Multicentric Analysis of 2,351 Patients With Myelodysplastic Syndromes Indicates an Underestimation of Poor-Risk Cytogenetics of Myelodysplastic Syndromes in the International Prognostic Scoring System

(2011) Julie Schanz et al.   JOURNAL OF CLINICAL ONCOLOGY

Flow cytometric scoring system as a diagnostic and prognostic tool in myelodysplastic syndromes

(2011) Sung-Chao Chu et al.   LEUKEMIA RESEARCH

Implementation of flow cytometry in the diagnostic work-up of myelodysplastic syndromes in a multicenter approach: Report from the Dutch Working Party on Flow Cytometry in MDS

(2011) Theresia M. Westers et al.   LEUKEMIA RESEARCH

Role of flow cytometry in diagnostics of myelodysplastic syndromes—beyond the WHO 2008 classification

(2011) Anna Porwit   SEMINARS IN DIAGNOSTIC PATHOLOGY

Classification of Childhood Aplastic Anemia and Myelodysplastic Syndrome

(2011) C. M. Niemeyer et al.   Hematology-American Society of Hematology Education Program

Flow cytometric scoring system (FCMSS) assisted diagnosis of myelodysplastic syndromes (MDS) and the biological significance of FCMSS-based immunophenotypes

(2010) Feng Xu et al.   BRITISH JOURNAL OF HAEMATOLOGY

Clinical utility of multiparameter flow cytometry in the diagnosis of 1013 patients with suspected myelodysplastic syndrome

(2010) Wolfgang Kern et al.   CANCER

Aberrant immunophenotype of blasts in myelodysplastic syndromes is a clinically relevant biomarker in predicting response to growth factor treatment

(2009) T. M. Westers et al.   BLOOD

Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation study

(2009) K. Ogata et al.   HAEMATOLOGICA

Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes

(2009) A. A. van de Loosdrecht et al.   HAEMATOLOGICA

The utility of flow cytometric immunophenotyping in cytopenic patients with a non-diagnostic bone marrow: A prospective study

(2009) Francoise Truong et al.   LEUKEMIA RESEARCH

The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34+ hematopoietic cells allows discrimination between normal/reactive and myelodysplastic syndrome precursors

(2008) S Matarraz et al.   LEUKEMIA

Advanced pediatric myelodysplastic syndromes: Can immunophenotypic characterization of blast cells be a diagnostic and prognostic tool?

(2008) Marinella Veltroni et al.   PEDIATRIC BLOOD & CANCER